Leukemia inhibitory factor regulates trophoblast giant cell differentiation via janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway

Molecular Endocrinology

Volumn 22, Issue 7, 2008, Pages 1673-1681

  Takahashi, Yutaka ^a,b   Takahashi, Michiko ^a,b   Carpino, Nick ^b   Jou, Shiann Tarng ^b   Chao, Jyh Rong ^b   Tanaka, Satoshi ^c   Shigeyoshi, Yasufumi ^d   Parganas, Evan ^b   Ihle, James N ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 1; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; GIANT CELL; LETHALITY; MOUSE; NONHUMAN; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL; TROPHOBLAST;

ANIMALS; CELL DIFFERENTIATION; CROSSES, GENETIC; GENES, DOMINANT; GIANT CELLS; HETEROZYGOTE; JANUS KINASE 1; LEUKEMIA INHIBITORY FACTOR; MICE; MICROSCOPY, FLUORESCENCE; RATS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TROPHOBLASTS;

MUS;

EID: 46349097234     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0058     Document Type: Article

References (22)

1. Simmons DG, Cross JC 2005 Determinants of trophoblast lineage and cell subtype specification in the mouse placenta. Dev Biol 284:12-24
2. Hemberger M 2008 IFPA Award in Placentology Lecture. Characteristics and significance of trophoblast giant cells. Placenta 29S:4-9
3. Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S 1994 Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6β receptor components. Science 263:92-95
4. Rodig SJ, Meraz MA, White JM, Lampe PA, Riley JK, Arthur CD, King KL, Sheehan KC, Yin L, Pennica D, Johnson Jr EM, Schreiber RD 1998 Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93:373-383
5. Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Grosveld G, Ihle JN 1998 Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93:385-395
6. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ 1997 A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921
7. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ 1992 Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359:76-79
8. Ware CB, Horowitz MC, Renshaw BR, Hunt JS, Liggitt D, Koblar SA, Gliniak BC, McKenna HJ, Papayannopoulou T, Thoma B, Cheng L, Donovan PJ, Peschonl JJ, Bartlett PF, Willis CR, Wright BD, Carpenter MK, Davison BL, Gearing DP 1995 Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121:1283-1299
9. Takahashi Y, Carpino N, Cross JC, Torres M, Parganas E, Ihle JN 2003 SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J 22:372-384
10. Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, Nicola NA, Metcalf D, Hilton DJ, Alexander WS 2001 Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci USA 98:9324-9329
11. Robb L, Boyle K, Rakar S, Hartley L, Lochland J, Roberts AW, Alexander WS, Metcalf D 2005 Genetic reduction of embryonic leukemia-inhibitory factor production rescues placentation in SOCS3-null embryos but does not prevent inflammatory disease. Proc Natl Acad Sci USA 102:16333-16338
12. Sahgal N, Canham LN, Canham B, Soares MJ 2006 Rcho-1 trophoblast stem cells: a model system for studying trophoblast cell differentiation. Methods Mol Med 121:159-178
13. Takahashi Y, Dominici M, Swift J, Nagy C, Ihle JN 2006 Trophoblast stem cells rescue placental defect in SOCS3-deficient mice. J Biol Chem 281:11444-11445
14. Cross JC, Nakano H, Natale DR, Simmons DG, Watson ED 2006 Branching morphogenesis during development of placental villi. Differentiation 74:393-401
15. Huang S 2007 Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res 13:1362-1366
16. Sexl V, Kovacic B, Piekorz R, Moriggl R, Stoiber D, Hoffmeyer A, Liebminger R, Kudlacek O, Weisz E, Rothammer K, Ihle JN 2003 Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation. Blood 101:4937-4943
17. Faria TN, Soares MJ 1991 Trophoblast cell differentiation: establishment, characterization, and modulation placental prolactin family. Endocrinology 129:2895-2906
18. Nakajima H, Ihle JN 2001 Granulocyte colony-stimulating factor regulates myeloid differentiation through CCAAT/enhancer-binding protein ε. Blood 98:897-905
19. Cross JC, Flannery ML, Blanar MA, Steingrimsson E, Jenkins NA, Copeland NG, Rutter WJ, Werb Z 1995 Hxt encodes a basic helix-loop-helix transcription factor that regulates trophoblast cell development. Development 121:2513-2523
20. Tanaka S, Kunath T, Hadjantonakis AK, Nagy A, Rossant J 1998 Promotion of trophoblast stem cell proliferation by FGF4. Science 282:2072-2075
21. Simmons DG, Fortier AL, Cross JC 2007 Diverse subtypes and developmental origins of trophoblast giant cells in the mouse placenta. Dev Biol 304:567-578
22. Takahashi Y, Shirono H, Arisaka O, Takahashi K, Yagi T, Koga J, Kaji H, Okimura Y, Abe H, Tanaka T, Chihara K 1997 Biologically inactive growth hormone caused by an amino acid substitution. J Clin Invest 100:1159-1165